Three-Month FVC Change: A Trial Endpoint for Idiopathic Pulmonary Fibrosis Based on Individual Participant Data Meta-analysis

Subjects

Subjects :

interstitial lung disease
Pulmonary and Respiratory Medicine
Science & Technology
MORTALITY
BOSENTAN
Respiratory System
spirometry
PIRFENIDONE
Vital Capacity
6-minute-walk test
gas transfer for carbon monoxide
EFFICACY
Critical Care and Intensive Care Medicine
Idiopathic Pulmonary Fibrosis
Critical Care Medicine
BIAS
General & Internal Medicine
Disease Progression
Humans
Life Sciences & Biomedicine
11 Medical and Health Sciences
Proportional Hazards Models

Details

ISSN :

15354970 and 1073449X

Volume :

205

Database :

OpenAIRE

Journal :

American Journal of Respiratory and Critical Care Medicine

Accession number :

edsair.doi.dedup.....8d3b9e1fa7ebe11b3cd86d221b9edded